Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Gerhard Frey"'
Autor:
Gerhard Frey, Ana Paula G. Cugnetti, Haizhen Liu, Charles Xing, Christina Wheeler, Hwai Wen Chang, William J. Boyle, Jay M. Short
Publikováno v:
mAbs, Vol 16, Iss 1 (2024)
ABSTRACTEpithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein that plays several roles in cancer biology. EpCAM is an attractive therapeutic target because of its expression in most solid tumors. However, targeting EpCAM has been
Externí odkaz:
https://doaj.org/article/7fc31e7a3b674b338e4ac1b2672d0edf
Autor:
Jing Wang, Wei Zhou, Ana Paula G Cugnetti, Mathew Lucas, Haizhen Liu, Charles Xing, Patty McNeely, Solimarie Joyner, Kyrie Johnson, Kathryn Woodard, Cathy Chang, Gerhard Frey, William J Boyle, Jay M Short
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d933f3b17c434ab3ac5043d156c3ee2c
Autor:
Wei Zhou, Ana Paula G Cugnetti, Mathew Lucas, Haizhen Liu, Charles Xing, Solimarie Joyner, Kyrie Johnson, Kathryn Woodard, Cathy Chang, Gerhard Frey, William J Boyle, Jay M Short, Patricia McNeeley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c6858652b2444bd089373159245edfe0
Autor:
Ana Paula Cugnetti, Haizhen Liu, Patricia McNeeley, Christina Wheeler, Matthew Lucas, Charles Xing, Solmarie Joyner, Kyrie Johnson, Kathryn Woodard, Wei Zhou, Cathy Chang, Gerhard Frey, William J. Boyle, Jay M. Short
Publikováno v:
Cancer Research. 83:1871-1871
Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers and is associated with poor prognosis. Despite the outstanding improvement in survival with the introduction of anti-HER2 therapies, therapeutic benefit is limited b
Autor:
Matthew Lucas, Ana Paula Cugnetti, Haizhen Liu, Charles Xing, Jing Wang, Patricia McNeeley, Christina Wheeler, Solmarie Joyner, Kyrie Johnson, Kathryn Woodard, Wei Zhou, Cathy Chang, Gerhard Frey, William J. Boyle, Jay M. Short
Publikováno v:
Cancer Research. 83:1879-1879
Nectin-4 is a Ca2+ independent immunoglobulin-like protein that is primarily involved in cell-cell adhesion. Nectin-4 is overexpressed in several tumor types, including breast, lung, urothelial, colorectal, pancreatic, and ovarian cancers. Overexpres
Autor:
Jian Chen, Jing Wang, Matt Lucas, Haizhen Liu, Christina Wheeler, Kyrie Johnson, Kathryn Woodard, Cathy Chang, Gerhard Frey, William J. Boyle, Jay M. Short
Publikováno v:
Cancer Research. 83:B022-B022
Cellular senescence is characterized by stable cell cycle arrest and a secretory program that modulates the tissue microenvironment. The aberrant accumulation of senescent cells in aged and cancerous tissue triggers inflammatory signaling through a s
Autor:
Gerhard Frey, Tony Shaska
Publikováno v:
Algebraic Curves and Their Applications. :279-344
The main purpose of this paper is to give an overview over the theory of abelian varieties, with main focus on Jacobian varieties of curves reaching from well-known results till to latest developments and their usage in cryptography. In the first par
Autor:
Haizhen Liu, Hwai Wen Chang, Jay M. Short, Lawrence Steinman, Charles Xing, Gerhard Frey, William J. Boyle
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance On-target, off-tumor toxicity of anti-CTLA4 checkpoint inhibitors leads to severe adverse events, restricting therapeutic efficacy. We engineered anti-CTLA4 antibodies and generated a new class of antibodies referred to as conditionally
Autor:
Christina Wheeler, Jing Wang, Haizhen Liu, Ana Paula G. Cugnetti, William J. Boyle, Jay M. Short, Cathy Chang, Charles Xing, Gerhard Frey, Matthew Lucas
Publikováno v:
Cancer Research. 81:1870-1870
The use of CD3/target bispecific molecules has great therapeutic potential in oncology. This potential, however, is diminished due to severe cytokine release effects as well as serious on-target off-tumor toxicities. Conditionally Active Biologic (CA
Autor:
Ana Paula G. Cugnetti, Matthew Lucas, Christina Wheeler, Haizhen Liu, Cathy Chang, Charles Xing, William J. Boyle, Jay M. Short, Jing Wang, Gerhard Frey
Publikováno v:
Cancer Research. 80:5698-5698
The use of CD3/target bispecific molecules has great therapeutic potential in oncology. This potential, however, is diminished due to serious on-target drug-related toxicities, restricting the development of bispecific T cell engagers to targets that